Skip to main content
Erschienen in: Annals of Surgical Oncology 3/2017

05.10.2016 | Breast Oncology

Variation in the Types of Providers Participating in Breast Cancer Follow-Up Care: A SEER-Medicare Analysis

verfasst von: Heather B. Neuman, MD, MS, Jessica R. Schumacher, PhD, David F. Schneider, MD, Emily R. Winslow, MD, Rebecca A. Busch, MD, Jennifer L. Tucholka, BS, Maureen A. Smith, MD, MPH, PhD, Caprice C. Greenberg, MD, MPH

Erschienen in: Annals of Surgical Oncology | Ausgabe 3/2017

Einloggen, um Zugang zu erhalten

Abstract

Background

The current guidelines do not delineate the types of providers that should participate in early breast cancer follow-up care (within 3 years after completion of treatment). This study aimed to describe the types of providers participating in early follow-up care of older breast cancer survivors and to identify factors associated with receipt of follow-up care from different types of providers.

Methods

Stages 1–3 breast cancer survivors treated from 2000 to 2007 were identified in the Surveillance, Epidemiology and End results Medicare database (n = 44,306). Oncologist (including medical, radiation, and surgical) follow-up and primary care visits were defined using Medicare specialty provider codes and linked American Medical Association (AMA) Masterfile. The types of providers involved in follow-up care were summarized. Stepped regression models identified factors associated with receipt of medical oncology follow-up care and factors associated with receipt of medical oncology care alone versus combination oncology follow-up care.

Results

Oncology follow-up care was provided for 80 % of the patients: 80 % with a medical oncologist, 46 % with a surgeon, and 39 % with a radiation oncologist after radiation treatment. The patients with larger tumor size, positive axillary nodes, estrogen receptor (ER)-positive status, and chemotherapy treatment were more likely to have medical oncology follow-up care than older patients with higher Charlson comorbidity scores who were not receiving axillary care. The only factor associated with increased likelihood of follow-up care with a combination of oncology providers was regular primary care visits (>2 visits/year).

Conclusions

Substantial variation exists in the types of providers that participate in breast cancer follow-up care. Improved guidance for the types of providers involved and delineation of providers’ responsibilities during follow-up care could lead to improved efficiency and quality of care.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Khatcheressian JL, Hurley P, Bantug E, et al. Breast cancer follow-up and management after primary treatment: American society of clinical oncology clinical practice guideline update. J Clin Oncol. 2013;31:961–5.CrossRefPubMed Khatcheressian JL, Hurley P, Bantug E, et al. Breast cancer follow-up and management after primary treatment: American society of clinical oncology clinical practice guideline update. J Clin Oncol. 2013;31:961–5.CrossRefPubMed
3.
4.
Zurück zum Zitat Margenthaler JA, Allam E, Chen L, et al. Surveillance of patients with breast cancer after curative-intent primary treatment: current practice patterns. J Oncol Pract. 2012;8:79–83.CrossRefPubMed Margenthaler JA, Allam E, Chen L, et al. Surveillance of patients with breast cancer after curative-intent primary treatment: current practice patterns. J Oncol Pract. 2012;8:79–83.CrossRefPubMed
5.
Zurück zum Zitat Grunfeld E, Hodgson DC, Del Giudice ME, Moineddin R. Population-based longitudinal study of follow-up care for breast cancer survivors. J Oncol Pract. 2010;6:174–81.CrossRefPubMedPubMedCentral Grunfeld E, Hodgson DC, Del Giudice ME, Moineddin R. Population-based longitudinal study of follow-up care for breast cancer survivors. J Oncol Pract. 2010;6:174–81.CrossRefPubMedPubMedCentral
6.
Zurück zum Zitat Neuman HB, Weiss JM, Schrag D, et al. Patient demographic and tumor characteristics influencing oncologist follow-up frequency in older breast cancer survivors. Ann Surg Oncol. 2013;20:4128–36.CrossRefPubMed Neuman HB, Weiss JM, Schrag D, et al. Patient demographic and tumor characteristics influencing oncologist follow-up frequency in older breast cancer survivors. Ann Surg Oncol. 2013;20:4128–36.CrossRefPubMed
7.
Zurück zum Zitat Neuman HB, Rathouz PJ, Winslow ER, et al. Use of a novel statistical technique to examine the delivery of breast cancer follow-up care by different types of oncology providers. J Eval Clin Pract. 2016;22(5):737–44.CrossRefPubMed Neuman HB, Rathouz PJ, Winslow ER, et al. Use of a novel statistical technique to examine the delivery of breast cancer follow-up care by different types of oncology providers. J Eval Clin Pract. 2016;22(5):737–44.CrossRefPubMed
8.
Zurück zum Zitat Institute of Medicine (IOM). Crossing the quality chasm: a new health system for the 21st century. Washington, DC: National Academy Press; 2001. Institute of Medicine (IOM). Crossing the quality chasm: a new health system for the 21st century. Washington, DC: National Academy Press; 2001.
9.
Zurück zum Zitat Mariotto AB, Yabroff KR, Shao Y, Feuer EJ, Brown ML. Projections of the cost of cancer care in the United States: 2010–2020. J Natl Cancer Institute. 2011;103:117–28.CrossRef Mariotto AB, Yabroff KR, Shao Y, Feuer EJ, Brown ML. Projections of the cost of cancer care in the United States: 2010–2020. J Natl Cancer Institute. 2011;103:117–28.CrossRef
10.
Zurück zum Zitat The state of cancer care in America, 2014: a report by the American Society of Clinical Oncology. J Oncol Pract. 2014;10:119–42.CrossRef The state of cancer care in America, 2014: a report by the American Society of Clinical Oncology. J Oncol Pract. 2014;10:119–42.CrossRef
11.
Zurück zum Zitat American Cancer Society. Cancer facts & figures. Atlanta, GA; 2016. American Cancer Society. Cancer facts & figures. Atlanta, GA; 2016.
12.
Zurück zum Zitat Keating NL, Landrum MB, Guadagnoli E, Winer EP, Ayanian JZ. Factors related to underuse of surveillance mammography among breast cancer survivors. J Clin Oncol. 2006;24:85–94.CrossRefPubMed Keating NL, Landrum MB, Guadagnoli E, Winer EP, Ayanian JZ. Factors related to underuse of surveillance mammography among breast cancer survivors. J Clin Oncol. 2006;24:85–94.CrossRefPubMed
13.
Zurück zum Zitat Lamont EB, Herndon JE II, Weeks JC, et al. Measuring disease-free survival and cancer relapse using Medicare claims from CALGB breast cancer trial participants (companion to 9344). J Natl Cancer Institute. 2006;98:1335–8.CrossRef Lamont EB, Herndon JE II, Weeks JC, et al. Measuring disease-free survival and cancer relapse using Medicare claims from CALGB breast cancer trial participants (companion to 9344). J Natl Cancer Institute. 2006;98:1335–8.CrossRef
14.
Zurück zum Zitat Smith BD, Gross CP, Smith GL, Galusha DH, Bekelman JE, Haffty BG. Effectiveness of radiation therapy for older women with early breast cancer. J Natl Cancer Institute. 2006;98:681–90.CrossRef Smith BD, Gross CP, Smith GL, Galusha DH, Bekelman JE, Haffty BG. Effectiveness of radiation therapy for older women with early breast cancer. J Natl Cancer Institute. 2006;98:681–90.CrossRef
15.
Zurück zum Zitat Stokes ME, Thompson D, Montoya EL, Weinstein MC, Winer EP, Earle CC. Ten-year survival and cost following breast cancer recurrence: estimates from SEER-Medicare data. Value Health. 2008;11:213–20.CrossRefPubMed Stokes ME, Thompson D, Montoya EL, Weinstein MC, Winer EP, Earle CC. Ten-year survival and cost following breast cancer recurrence: estimates from SEER-Medicare data. Value Health. 2008;11:213–20.CrossRefPubMed
16.
Zurück zum Zitat Pollack LA, Adamache W, Eheman CR, Ryerson AB, Richardson LC. Enhancement of identifying cancer specialists through the linkage of Medicare claims to additional sources of physician specialty. Health Serv Res. 2009;44(2 Pt 1):562–76.CrossRefPubMedPubMedCentral Pollack LA, Adamache W, Eheman CR, Ryerson AB, Richardson LC. Enhancement of identifying cancer specialists through the linkage of Medicare claims to additional sources of physician specialty. Health Serv Res. 2009;44(2 Pt 1):562–76.CrossRefPubMedPubMedCentral
17.
Zurück zum Zitat Baldwin LM, Adamache W, Klabunde CN, Kenward K, Dahlman C, Warren JL. Linking physician characteristics and Medicare claims data: issues in data availability, quality, and measurement. Med Care. 2002;40(8suppl):IV82–95.CrossRef Baldwin LM, Adamache W, Klabunde CN, Kenward K, Dahlman C, Warren JL. Linking physician characteristics and Medicare claims data: issues in data availability, quality, and measurement. Med Care. 2002;40(8suppl):IV82–95.CrossRef
18.
Zurück zum Zitat Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. 1992;45:613–9.CrossRefPubMed Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. 1992;45:613–9.CrossRefPubMed
19.
Zurück zum Zitat Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373–83.CrossRefPubMed Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373–83.CrossRefPubMed
20.
Zurück zum Zitat AJCC cancer staging manual. 6th ed. Springer, New York, 2002. AJCC cancer staging manual. 6th ed. Springer, New York, 2002.
21.
Zurück zum Zitat Cheung WY, Aziz N, Noone AM, et al. Physician preferences and attitudes regarding different models of cancer survivorship care: a comparison of primary care providers and oncologists. J Cancer Survivorship Res Pract. 2013;7:343–54.CrossRef Cheung WY, Aziz N, Noone AM, et al. Physician preferences and attitudes regarding different models of cancer survivorship care: a comparison of primary care providers and oncologists. J Cancer Survivorship Res Pract. 2013;7:343–54.CrossRef
22.
Zurück zum Zitat Potosky AL, Han PK, Rowland J, et al. Differences between primary care physicians’ and oncologists’ knowledge, attitudes, and practices regarding the care of cancer survivors. J Gen Intern Med. 2011;26:1403–10.CrossRefPubMedPubMedCentral Potosky AL, Han PK, Rowland J, et al. Differences between primary care physicians’ and oncologists’ knowledge, attitudes, and practices regarding the care of cancer survivors. J Gen Intern Med. 2011;26:1403–10.CrossRefPubMedPubMedCentral
23.
Zurück zum Zitat Kantsiper M, McDonald EL, Geller G, Shockney L, Snyder C, Wolff AC. Transitioning to breast cancer survivorship: perspectives of patients, cancer specialists, and primary care providers. J Gen Intern Med. 2009;24(Suppl 2):S459–66.CrossRefPubMed Kantsiper M, McDonald EL, Geller G, Shockney L, Snyder C, Wolff AC. Transitioning to breast cancer survivorship: perspectives of patients, cancer specialists, and primary care providers. J Gen Intern Med. 2009;24(Suppl 2):S459–66.CrossRefPubMed
24.
Zurück zum Zitat Cheung WY, Neville BA, Cameron DB, Cook EF, Earle CC. Comparisons of patient and physician expectations for cancer survivorship care. J Clin Oncol. 2009;27:2489–95.CrossRefPubMed Cheung WY, Neville BA, Cameron DB, Cook EF, Earle CC. Comparisons of patient and physician expectations for cancer survivorship care. J Clin Oncol. 2009;27:2489–95.CrossRefPubMed
25.
Zurück zum Zitat Hewitt ME, Bamundo A, Day R, Harvey C. Perspectives on posttreatment cancer care: qualitative research with survivors, nurses, and physicians. J Clin Oncol. 2007;25:2270–3.CrossRefPubMed Hewitt ME, Bamundo A, Day R, Harvey C. Perspectives on posttreatment cancer care: qualitative research with survivors, nurses, and physicians. J Clin Oncol. 2007;25:2270–3.CrossRefPubMed
26.
Zurück zum Zitat Friese CR, Martinez KA, Abrahamse P, et al. Providers of follow-up care in a population-based sample of breast cancer survivors. Breast Cancer Res Treat. 2014;144:179–84.CrossRefPubMedPubMedCentral Friese CR, Martinez KA, Abrahamse P, et al. Providers of follow-up care in a population-based sample of breast cancer survivors. Breast Cancer Res Treat. 2014;144:179–84.CrossRefPubMedPubMedCentral
27.
Zurück zum Zitat Neuman HB, Steffens NM, Jacobson N, et al. Oncologists’ perspectives of their roles and responsibilities during multidisciplinary breast cancer follow-up. Ann Surg Oncol. 2016;23:708–14.CrossRefPubMed Neuman HB, Steffens NM, Jacobson N, et al. Oncologists’ perspectives of their roles and responsibilities during multidisciplinary breast cancer follow-up. Ann Surg Oncol. 2016;23:708–14.CrossRefPubMed
28.
Zurück zum Zitat Freeborn DK, Pope CR, Mullooly JP, McFarland BH. Consistently high users of medical care among the elderly. Med Care. 1990;28:527–40.CrossRefPubMed Freeborn DK, Pope CR, Mullooly JP, McFarland BH. Consistently high users of medical care among the elderly. Med Care. 1990;28:527–40.CrossRefPubMed
29.
30.
Zurück zum Zitat Giordano SH, Hortobagyi GN, Kau SW, Theriault RL, Bondy ML. Breast cancer treatment guidelines in older women. J Clin Oncol. 2005;23:783–91.CrossRefPubMed Giordano SH, Hortobagyi GN, Kau SW, Theriault RL, Bondy ML. Breast cancer treatment guidelines in older women. J Clin Oncol. 2005;23:783–91.CrossRefPubMed
31.
Zurück zum Zitat Owusu C, Lash TL, Silliman RA. Effect of undertreatment on the disparity in age-related breast cancer-specific survival among older women. Breast Cancer Res Treat. 2007;102:227–36.CrossRefPubMed Owusu C, Lash TL, Silliman RA. Effect of undertreatment on the disparity in age-related breast cancer-specific survival among older women. Breast Cancer Res Treat. 2007;102:227–36.CrossRefPubMed
Metadaten
Titel
Variation in the Types of Providers Participating in Breast Cancer Follow-Up Care: A SEER-Medicare Analysis
verfasst von
Heather B. Neuman, MD, MS
Jessica R. Schumacher, PhD
David F. Schneider, MD
Emily R. Winslow, MD
Rebecca A. Busch, MD
Jennifer L. Tucholka, BS
Maureen A. Smith, MD, MPH, PhD
Caprice C. Greenberg, MD, MPH
Publikationsdatum
05.10.2016
Verlag
Springer International Publishing
Erschienen in
Annals of Surgical Oncology / Ausgabe 3/2017
Print ISSN: 1068-9265
Elektronische ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-016-5611-7

Weitere Artikel der Ausgabe 3/2017

Annals of Surgical Oncology 3/2017 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.